CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

NCT06641453 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: GPC3-CART cells
DRUG: Fludarabine Phosphate for Injection
DRUG: Cyclophosphamide for Injection

Sponsor

Chinese PLA General Hospital